Pharmaceuticals and life sciences

We are transitioning to an era where commercial success for pharmaceuticals will depend on profitably managing contingency-based payer agreements.   As real world evidence (RWE) becomes more consistent and comprehensive, payers will place the onus on drug makers to guarantee outcomes.

This new access environment, combined with scientific breakthroughs, developments in alternative medicines, and emerging digital and analytic capabilities is pushing companies to explore unconventional business models and build value-based customer relationships.

PwC Canada's Pharma Life Sciences practice helps pharmaceutical, biotech, medical device, pharmacy and medical cannabis companies with all aspects of this transition.

We will work with you to develop future focused business strategies and implement the time critical programs and procedures essential to success within the Canadian regulatory frameworks.